Publications by authors named "Stephen P Anthony"

Claim this Profile
L
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia.
Janani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, Xiaokui Mo, Tzung-Huei Lai, Stephen P Anthony

Haematologica· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, Bart Eisfelder, Anika Thomas-Toth, Stephen P Anthony

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Charles Peterfy, Yan Chen, Peter Countryman, Bartosz Chmielowski, Stephen P Anthony

Future Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Mariaelena Pierobon, Nicholas J Robert, Donald W Northfelt, Mohammad Jahanzeb, Shukmei Wong, Stephen P Anthony

Mol Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
William D Tap, Arun S Singh, Stephen Patrick Anthony, Mike Sterba, Chao Zhang

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia.
Joshua F Zeidner, Daniel J Lee, Mark Frattini, Gil D Fine, Judy Costas, Stephen P Anthony

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
Eric M Cheung, William J Edenfield, Bassam Mattar, Stephen P Anthony, Peter J Mutch

J Clin Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Mariaelena Pierobon, Corinne Ramos, Shukmei Wong, K Alex Hodge, Jessica Aldrich, Stephen P Anthony

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Heather L Gelhorn, Sandra Tong, Kelly McQuarrie, Christina Vernon, Jennifer Hanlon, Stephen P Anthony

Clin Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Pilar Ramos, Anthony N Karnezis, William P D Hendricks, Yemin Wang, Waibhav Tembe, Stephen P Anthony

Rare Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
William D Tap, Zev A Wainberg, Stephen P Anthony, Prabha N Ibrahim, Chao Zhang

N Engl J Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Gayle S Jameson, Emanuel F Petricoin, Jasgit Sachdev, Lance A Liotta, David M Loesch, Stephen P Anthony

Breast Cancer Res Treat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
Pilar Ramos, Anthony N Karnezis, David W Craig, Aleksandar Sekulic, Megan L Russell, Stephen P Anthony

Nat Genet· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors.
Michael S Gordon, Lee S Rosen, David Mendelson, Ramesh K Ramanathan, Jonathan Goldman, Stephen P Anthony

Invest New Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer.
Glen J Weiss, Ross C Donehower, Tara Iyengar, Ramesh K Ramanathan, Karen Lewandowski, Stephen P Anthony

Invest New Drugs· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type.
Bret Stephens, Stephen P Anthony, Haiyong Han, Jeffery Kiefer, Galen Hostetter

J Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.
Robert M Eager, C Casey Cunningham, Neil N Senzer, Joe Stephenson, Stephen P Anthony

BMC Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.
Donald A Richards, Kristi A Boehm, Stephen P Anthony

Expert Opin Investig Drugs· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions.
Svetislava J Vukelja, Stephen P Anthony, James C Arseneau, Barry S Berman, C Casey Cunningham

Anticancer Drugs· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
Stephen E Jones, Michael A Savin, Frankie Ann Holmes, Joyce A O'Shaughnessy, Joanne L Blum, Stephen P Anthony

J Clin Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis